Devin Quinlan, Ph.D.
Investment and Operations Team
Dr. Devin Quinlan is responsible for investment identification, due diligence, business development, and company creation activities at MPM. Devin joined MPM full time in 2018 after completing an internship with the firm, and has since supported multiple investments across diverse therapeutic areas, including MPM’s investments into Orna Therapeutics and Triplet Therapeutics. Devin was also part of the founding team of a stealth oncology NewCo, where he is Head of Strategy & Operations and a Board Observer.
Prior to joining MPM, Devin completed his Ph.D. in Biological Engineering at the Massachusetts Institute of Technology (MIT) under advisor Ram Sasisekharan. His thesis was focused on uncovering structure-function relationships of antibodies which target viral antigens, including Ebola and Zika viruses. In addition to his academic research, Devin served as part of the inaugural leadership team of the MIT Biotech Group, which has since grown into the largest life-sciences student organization at MIT.
Devin received his B.S. in Bioengineering from the University of California, Los Angeles.